icon3

Ostomy Care Market Outlook to 2024 | Global Market Size, Share, Trends, Outlook, Opportunity Analysis, Forecast and Estimates

  • 23
  • |
  • Oct, 2018
  • |
  • Nephrology & Urology devices
  • |
  • Pages
  • |
  • Global

Market Overview, Key in-line Products, Market Share Distribution, Competitive Dynamics, Regulatory Outlook, Pipeline Development, Growth Catalysts & Challenges, Leading Market & R&D Trends, Partnership & Deals Analyses, Global Sales forecast of in-line and pipeline products, Fast Growing Private Companies, Management Perspectives, Commentaries, Market Outlook & Summary Conclusions
 
Global Ostomy Care market was valued at $2.7bn in 2015 and is forecast to grow at a modest 4.5% CAGR between 2015 and 2024 to reach sales of $4.2bn in 2024. Accessories are an important part of the product offering within ostomy care and include personal hygiene products for skin protection, odour removal and elastic tapes and belts for improved security.  
 
Europe dominates the ostomy care market and accounted for 55% of the market in 2015, although there is a growing contribution from emerging markets. In contrast, the U.S. is relatively small market and accounted for 15-20% of the global market.
 
“Treatment Algorithm”
Ostomy care products support patients with a stoma. A stoma is created in response to an intestinal dysfunction which results from disease, accident or congenital disorder. Stoma is a surgically created opening in the abdominal wall providing a means for waste to leave the body. The main reason for such surgeries is cancer.
 
Depending on the surgical types Ostomy Care market is segmented in to 3 key categories, namely Urostomy, Colostomy and ileostomy. Both ileostomies and colostomies are reversible, while urostomies are permanent. Industry data suggests that 15% of all colostomy and ileostomy surgeries are temporary. According to industry sources, colorectal cancer accounts for 45% of surgeries and bladder cancer for 10%. Diverticultis and inflammatory bowel disease (IBD) account for 15% and 10%, respectively. A colostomy (end of colon is diverted) is still the most executed surgery followed by the Ileostomy (stoma directly located at the ileum) and urostomy (stoma for the urinary system).
 
“Epidemiology”
The exact incidence and prevalence of ostomy surgery is unknown. Currently there are over 2.5 million ostomy patients worldwide. Cooke (2009) used data from the Health Care Cost and Utilization Project and estimated a range of 650,000 to 730,000 people live with a permanent ostomy in the U.S. Approximately 140,000 people in the U.S. undergo operations that result in a colostomy or ileostomy each year. The high incidence of ostomy surgeries in the U.S. is due in part to the increasing prevalence of colorectal cancer and diverticular disease.
 
 
Global Ostomy Care Market, By Types, 2013 - 2024 (USD Million)  
 
 
 
“Hollister, Convatec and Coloplast the three key players in the ostomy care market"
 
The ostomy care market is highly concentrated around the three main players Hollister, Convatec and Coloplast, with a combined share of 90%. The rest of the market belongs to smaller local players such as B. Braun (Germany), Salts, Eakin-Pelikan, Welland (UK) and Alcare (Japan). Hollister is the clear leader in the US with about a 50% market share, and is also active in Japan and Australia.  Convatec, which was a subsidiary of Bristol-Myers until 2008 and is now held by the private equity firms Nordic Capital and Avista Capital, is number three in the global market, with about a 30% share. Convatec is more globally present than Hollister, with a strong position in Europe, a leading position in Latin America, and a smaller position in Asia.  
“Reimbursement Insights”
 
Ostomy care is well reimbursed in the U.S. market.  In the U.S, MediCare funds roughly 75% of users with the rest of the market being private insured, which covers on average roughly 80% of the costs.  In general, ostomy bags tend to be re-used (roughly 25 bags per month).  Product choice is strongly impacted by the reimbursement environment. In countries where there is no reimbursement, patients tend to reuse the bags until they fall apart. Companies usually pitch to nurses and doctors who advise patients and influence purchasing decisions and hospital purchasing managers, rather than end-users, with nurses being the most important influencers.  
 
Growth in ostomy care is driven by demographics, the increasing prevalence of colon cancer, and earlier detection that results in longer treatment of ostomy patients. Further, the market is impacted by a differentiated product portfolio with focus around ease-of-use and the reduction of leakage and odor. Innovation is an important factor for success and driver of market share gains and price increases. Equally important is market access through the right distribution partners and access to all major purchasing contracts.

Market Overview, Key in-line Products, Market Share Distribution, Competitive Dynamics, Regulatory Outlook, Pipeline Development, Growth Catalysts & Challenges, Leading Market & R&D Trends, Partnership & Deals Analyses, Global Sales forecast of in-line and pipeline products, Fast Growing Private Companies, Management Perspectives, Commentaries, Market Outlook & Summary Conclusions
 
Global Ostomy Care market was valued at $2.7bn in 2015 and is forecast to grow at a modest 4.5% CAGR between 2015 and 2024 to reach sales of $4.2bn in 2024. Accessories are an important part of the product offering within ostomy care and include personal hygiene products for skin protection, odour removal and elastic tapes and belts for improved security.  
 
Europe dominates the ostomy care market and accounted for 55% of the market in 2015, although there is a growing contribution from emerging markets. In contrast, the U.S. is relatively small market and accounted for 15-20% of the global market.
 
“Treatment Algorithm”
Ostomy care products support patients with a stoma. A stoma is created in response to an intestinal dysfunction which results from disease, accident or congenital disorder. Stoma is a surgically created opening in the abdominal wall providing a means for waste to leave the body. The main reason for such surgeries is cancer.
 
Depending on the surgical types Ostomy Care market is segmented in to 3 key categories, namely Urostomy, Colostomy and ileostomy. Both ileostomies and colostomies are reversible, while urostomies are permanent. Industry data suggests that 15% of all colostomy and ileostomy surgeries are temporary. According to industry sources, colorectal cancer accounts for 45% of surgeries and bladder cancer for 10%. Diverticultis and inflammatory bowel disease (IBD) account for 15% and 10%, respectively. A colostomy (end of colon is diverted) is still the most executed surgery followed by the Ileostomy (stoma directly located at the ileum) and urostomy (stoma for the urinary system).
 
“Epidemiology”
The exact incidence and prevalence of ostomy surgery is unknown. Currently there are over 2.5 million ostomy patients worldwide. Cooke (2009) used data from the Health Care Cost and Utilization Project and estimated a range of 650,000 to 730,000 people live with a permanent ostomy in the U.S. Approximately 140,000 people in the U.S. undergo operations that result in a colostomy or ileostomy each year. The high incidence of ostomy surgeries in the U.S. is due in part to the increasing prevalence of colorectal cancer and diverticular disease.
 
 
Global Ostomy Care Market, By Types, 2013 - 2024 (USD Million)  
 
 
 
“Hollister, Convatec and Coloplast the three key players in the ostomy care market"
 
The ostomy care market is highly concentrated around the three main players Hollister, Convatec and Coloplast, with a combined share of 90%. The rest of the market belongs to smaller local players such as B. Braun (Germany), Salts, Eakin-Pelikan, Welland (UK) and Alcare (Japan). Hollister is the clear leader in the US with about a 50% market share, and is also active in Japan and Australia.  Convatec, which was a subsidiary of Bristol-Myers until 2008 and is now held by the private equity firms Nordic Capital and Avista Capital, is number three in the global market, with about a 30% share. Convatec is more globally present than Hollister, with a strong position in Europe, a leading position in Latin America, and a smaller position in Asia.  
“Reimbursement Insights”
 
Ostomy care is well reimbursed in the U.S. market.  In the U.S, MediCare funds roughly 75% of users with the rest of the market being private insured, which covers on average roughly 80% of the costs.  In general, ostomy bags tend to be re-used (roughly 25 bags per month).  Product choice is strongly impacted by the reimbursement environment. In countries where there is no reimbursement, patients tend to reuse the bags until they fall apart. Companies usually pitch to nurses and doctors who advise patients and influence purchasing decisions and hospital purchasing managers, rather than end-users, with nurses being the most important influencers.  
 
Growth in ostomy care is driven by demographics, the increasing prevalence of colon cancer, and earlier detection that results in longer treatment of ostomy patients. Further, the market is impacted by a differentiated product portfolio with focus around ease-of-use and the reduction of leakage and odor. Innovation is an important factor for success and driver of market share gains and price increases. Equally important is market access through the right distribution partners and access to all major purchasing contracts.


REPORT YOU MIGHT BE INTERESTED

Purchase this Report

Credit card Logo

Related Reports


Contact Us

Email Us at: sales@optimainsights.org | Reach Us at: +91 966 6620 365 | +1 424 2554 365 (US)